• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血再灌注损伤中预处理技术的临床应用:文献综述。

Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature.

机构信息

Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India.

Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Science, Tomsk, Russian Federation.

出版信息

Curr Cardiol Rev. 2021;17(3):306-318. doi: 10.2174/1573403X16999200817170619.

DOI:10.2174/1573403X16999200817170619
PMID:33109063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8640861/
Abstract

Ischemia refers to a reduced supply of oxygen and nutrient to the vital organ of the body. Reperfusion to the ischemic organ is the only way to salvage injury due to ischemia. Paradoxically, reperfusion itself induces the injury, which is more severe than the previous injury referred to as ischemia-reperfusion injury. Ischemia-reperfusion injury is the major cause of mortality in the case of ischemic diseases. The major hurdle for a clinician to treat ischemia is the reperfusion injury, which is encountered in different surgical as well as non-surgical situations. Several therapies, such as anti-platelets, anti-thrombolytic agents have been developed to contain ischemia-reperfusion injury, but with limited success. Over some time, some conditioning techniques such as preconditioning and postconditioning have been used by clinicians to overcome ischemia-reperfusion injury. The present review focuses on the clinical applications of different conditioning techniques in diverse pathological conditions of ischemia-reperfusion injury.

摘要

缺血是指身体重要器官的氧气和营养供应减少。再灌注是缺血器官挽救损伤的唯一方法。矛盾的是,再灌注本身会诱导损伤,这种损伤比之前的缺血再灌注损伤更为严重。缺血再灌注损伤是缺血性疾病导致死亡的主要原因。临床医生在治疗缺血时面临的主要障碍是再灌注损伤,这种损伤在不同的手术和非手术情况下都会出现。为了控制缺血再灌注损伤,已经开发了几种治疗方法,如抗血小板、溶栓剂等,但收效甚微。在一段时间内,临床医生使用了一些预处理和后处理等调节技术来克服缺血再灌注损伤。本综述重点介绍了不同调节技术在各种缺血再灌注损伤病理情况下的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4398/8640861/a53e594b1ac7/CCR-17-306_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4398/8640861/a53e594b1ac7/CCR-17-306_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4398/8640861/a53e594b1ac7/CCR-17-306_F1.jpg

相似文献

1
Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature.缺血再灌注损伤中预处理技术的临床应用:文献综述。
Curr Cardiol Rev. 2021;17(3):306-318. doi: 10.2174/1573403X16999200817170619.
2
Effects of Ischemic Preconditioning and Postconditioning in a Renal Ischemia-Reperfusion Injury Model: A Comparative Experimental Study in Rats.缺血预处理和后处理在肾缺血再灌注损伤模型中的作用:大鼠的一项对比实验研究
Transplant Proc. 2018 Dec;50(10):3811-3815. doi: 10.1016/j.transproceed.2018.07.021. Epub 2018 Nov 27.
3
Remote cardiac ischemic conditioning: underlying mechanisms and clinical applications.远程心脏缺血预处理:潜在机制与临床应用
Rev Port Cir Cardiotorac Vasc. 2012 Oct-Dec;19(4):183-90.
4
Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.保护心脏免受缺血/再灌注损伤:远程缺血预处理和后处理的最新进展
Curr Opin Cardiol. 2017 Nov;32(6):784-790. doi: 10.1097/HCO.0000000000000447.
5
The combined effect of rosuvastatin and ischemic pre- or post-conditioning on myocardial ischemia-reperfusion injury in rat heart.瑞舒伐他汀与缺血预处理或后处理联合对大鼠心脏心肌缺血再灌注损伤的影响。
Eur Rev Med Pharmacol Sci. 2015 Jul;19(13):2468-76.
6
Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.远程缺血预处理——一种来自心脏外的内源性心脏保护策略。
Chin Med J (Engl). 2011 Jul;124(14):2209-15.
7
Brief ischemia-reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats.在大鼠长时间缺血后进行短暂的缺血再灌注(缺血后处理)可终止再灌注心律失常,且不降低心脏功能。
Int Heart J. 2007 Mar;48(2):205-13. doi: 10.1536/ihj.48.205.
8
What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.心脏适应训练存在什么问题?我们可能是在对着移动目标射击。
J Cardiovasc Pharmacol Ther. 2015 Jul;20(4):357-69. doi: 10.1177/1074248414566459. Epub 2015 Jan 26.
9
Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.模拟心脏缺血/再灌注损伤条件作用的药物治疗。
J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):83-96. doi: 10.1177/1074248413499973. Epub 2013 Sep 13.
10
Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review.远程缺血预处理:一种预防缺血再灌注损伤的新型保护方法——综述
J Surg Res. 2008 Dec;150(2):304-30. doi: 10.1016/j.jss.2007.12.747. Epub 2008 Jan 22.

引用本文的文献

1
Exploration of the Potential Bioactive Compounds and Functional Mechanism of Chaihu Sanshen Capsule in Ameliorating Myocardial Ischaemia-Reperfusion Injury: A Serum Pharmaco-Chemistry With Network Pharmacology Analysis.柴胡三参胶囊改善心肌缺血再灌注损伤的潜在生物活性成分及作用机制探索:血清药物化学与网络药理学分析
J Cell Mol Med. 2025 Jul;29(14):e70666. doi: 10.1111/jcmm.70666.
2
VRAC channel inhibition as a novel strategy for the treatment of ischemia-reperfusion injury.VRAC通道抑制作为治疗缺血再灌注损伤的新策略。
Front Cell Dev Biol. 2024 Dec 23;12:1524723. doi: 10.3389/fcell.2024.1524723. eCollection 2024.
3

本文引用的文献

1
Ischemia-reperfusion injury: Complex pathophysiology with elusive treatment.缺血再灌注损伤:病理生理学复杂,治疗方法难以捉摸。
Hellenic J Cardiol. 2018 Nov-Dec;59(6):329-330. doi: 10.1016/j.hjc.2018.11.002. Epub 2018 Nov 16.
2
Comparison of hepatoprotective effect from ischemia-reperfusion injury of remote ischemic preconditioning of the liver vs local ischemic preconditioning of the liver during human liver resections.比较肝切除术时肝脏远隔缺血预处理与局部缺血预处理对肝缺血再灌注损伤的肝保护作用。
Int J Surg. 2018 Jun;54(Pt A):248-253. doi: 10.1016/j.ijsu.2018.05.001. Epub 2018 May 4.
3
Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI).
Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury.
用于在缺血/再灌注损伤中递送治疗剂的细胞外囊泡。
Asian J Pharm Sci. 2024 Dec;19(6):100965. doi: 10.1016/j.ajps.2024.100965. Epub 2024 Sep 4.
4
Amplification of Cardioprotective Response of Remote Ischemic Preconditioning in Rats by Quercetin: Potential Role of Activation of mTOR-dependent Autophagy and Nrf2.槲皮素增强大鼠远程缺血预处理的心脏保护反应:mTOR依赖性自噬和Nrf2激活的潜在作用
Cardiovasc Drugs Ther. 2024 Jun 25. doi: 10.1007/s10557-024-07595-9.
5
Annexin-A5 monomer as a membrane repair agent for the treatment of renal ischemia-reperfusion injury.膜修复剂 annexin-A5 单体治疗肾缺血再灌注损伤。
Mol Biol Rep. 2024 May 25;51(1):679. doi: 10.1007/s11033-024-09606-2.
6
Organ-Specific Mitochondrial Alterations Following Ischemia-Reperfusion Injury in Post-Cardiac Arrest Syndrome: A Comprehensive Review.心脏骤停综合征缺血再灌注损伤后器官特异性线粒体改变:综述
Life (Basel). 2024 Apr 5;14(4):477. doi: 10.3390/life14040477.
7
Advancing mouse models for transplantation research.推进用于移植研究的小鼠模型。
Am J Transplant. 2024 Aug;24(8):1362-1368. doi: 10.1016/j.ajt.2024.01.006. Epub 2024 Jan 12.
8
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.缺血再灌注损伤:分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x.
9
Unveiling Wide Spectrum Therapeutic Implications and Signaling Mechanisms of Valsartan in Diverse Disorders: A Comprehensive Review.揭示缬沙坦在多种疾病中的广泛治疗意义和信号机制:全面综述。
Curr Drug Res Rev. 2024;16(3):268-288. doi: 10.2174/2589977515666230717120828.
10
Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.腺苷信号在预处理技术心脏保护机制中的无尽探索:临床证据。
Curr Cardiol Rev. 2023;19(6):56-71. doi: 10.2174/1573403X19666230612112259.
上臂远程缺血后处理(RIPC)可减少急性 ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PCI)后的心肌缺血再灌注损伤。
Med Sci Monit. 2018 Feb 19;24:1017-1026. doi: 10.12659/msm.908247.
4
Limb remote ischemic post‑conditioning reduces injury and improves long‑term behavioral recovery in rats following subarachnoid hemorrhage: Possible involvement of the autophagic process.肢体远程缺血后处理可减轻大鼠蛛网膜下腔出血后损伤并改善长期行为学恢复:自噬过程的可能参与。
Mol Med Rep. 2018 Jan;17(1):21-30. doi: 10.3892/mmr.2017.7858. Epub 2017 Oct 24.
5
Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.保护心脏免受缺血/再灌注损伤:远程缺血预处理和后处理的最新进展
Curr Opin Cardiol. 2017 Nov;32(6):784-790. doi: 10.1097/HCO.0000000000000447.
6
Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.丙泊酚后处理通过 BRG1 介导的 Nrf2/HO-1 转录激活减轻人及小鼠肝缺血再灌注损伤。
J Cell Mol Med. 2017 Dec;21(12):3693-3704. doi: 10.1111/jcmm.13279. Epub 2017 Jul 27.
7
Impact of ischemic preconditioning on surgical treatment of brain tumors: a single-center, randomized, double-blind, controlled trial.缺血预处理对脑肿瘤外科治疗的影响:一项单中心、随机、双盲、对照试验。
BMC Med. 2017 Jul 25;15(1):137. doi: 10.1186/s12916-017-0898-1.
8
Remote Ischemic Preconditioning in Cardiac Surgery: Is There a Proven Clinical Benefit?心脏手术中的远程缺血预处理:是否有已证实的临床益处?
J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1910-1915. doi: 10.1053/j.jvca.2017.03.043. Epub 2017 Mar 31.
9
Remote ischaemic preconditioning in orthotopic liver transplantation (RIPCOLT trial): a pilot randomized controlled feasibility study.原位肝移植中的远程缺血预处理(RIPCOLT试验):一项初步随机对照可行性研究。
HPB (Oxford). 2017 Sep;19(9):757-767. doi: 10.1016/j.hpb.2017.05.005. Epub 2017 Jun 24.
10
Effect of thrombolytic therapy in plaque inflammation and structural remodeling in acute myocardial infarction patients.溶栓治疗对急性心肌梗死患者斑块炎症及结构重塑的影响。
Hellenic J Cardiol. 2017 Nov-Dec;58(6):446-449. doi: 10.1016/j.hjc.2017.06.002. Epub 2017 Jun 6.